RIBO TECT
BioNTech RNA Pharmaceuticals GmbH
Application Filed: 2019-08-06
Trademark Application Details
NON-FINAL ACTION - MAILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79268012 |
| Registration Number | 6171861 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | L10 |
| Employee Name | RUTLAND, BARBARA A |
Timeline
| 2019-08-06 | Application Filed |
| 2019-11-09 | Location: TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED |
| 2019-11-30 | Status: Live/Pending |
| 2019-12-20 | Transaction Date |
| 2020-10-13 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  BioNTech RNA Pharmaceuticals GmbH |
| Address | An der Goldgrube 12 55131 Mainz DE |
| Legal Entity Type | Limited Liability Partnership |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Chemical products for medical and veterinary purposes; medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions; medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleic acids; carriers and carrier systems for active ingredients, in particular for treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, or and metabolic disorders |
| GS0051 | Chemical reagents for medical and veterinary purposes; Medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleid acids for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of the active ingredients for pharmaceuticals for use in the treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2019-09-26 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-10-02 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2019-10-08 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2019-11-04 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2019-11-09 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2019-11-10 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2019-11-30 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2019-11-30 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2019-12-20 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-05-28 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-05-28 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-05-28 | 12 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-06-20 | 13 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-07-08 | 14 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2020-07-15 | 15 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2020-07-15 | 16 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2020-07-28 | 17 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-07-28 | 18 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2020-07-31 | 19 GPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2020-10-13 | 20 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2021-01-13 | 21 FICR P: |
| FINAL DISPOSITION PROCESSED | 2021-01-29 | 22 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2021-01-29 | 23 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2021-02-20 | 24 FINO P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2021-11-19 | 25 ADCH M: |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2024-05-30 | 26 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2024-05-30 | 27 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2024-05-30 | 28 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2024-05-30 | 29 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2024-05-30 | 30 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2024-05-30 | 31 TCCA I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 